The move by drug major Cipla's group company, Meditab Specialities, to seek legal action to get clarity on the future of its special economic zone (SEZ) project in Goa is likely to make others notified zone developers follow suit.
"We want to know who will compensate us for the losses if the SEZ is going to be cancelled? We hope the Court will address this issue," said Amar Lulla, joint managing director, Cipla Ltd.
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |